Dans l'actu de nos entreprises: Diagenode, augmentation de capital de 7,5 millions

The capital included an equity component provided by Epimède SA, SRIW SA, OBI SA and the Capricorn Health-tech Fund NV (CHF, Leuven, Belgium) which is managed by Capricorn Venture Partners NV combined with a loan facility provided by SRIW, OBI and SpinVenture.

In conjunction with the funding, Dr. Frank Bulens, Partner at Capricorn Venture Partners, Marc Foidart founder of Epimède and Philippe Degeer, will join Diagenode’s board of directors...

Read more

Category :   News